Our team is developing measurement tools that feed into structured analytical data models. We are focused on neurodegenerative diseases starting with Multiple Sclerosis (MS).
Location: United States, California, Menlo Park
Employees: 11-50
Total raised: $86M
Founded date: 2016
Investors 3
Date | Name | Website |
- | S32 | s32.com |
- | Section 32 | section32.... |
- | Blue Ventu... | blueventur... |
Funding Rounds 4
Date | Series | Amount | Investors |
16.11.2023 | Grant | $10M | - |
28.07.2023 | Series B | $30M | - |
20.12.2020 | Series B | $32M | - |
12.07.2018 | Series A | $14M | - |
Mentions in press and media 14
Date | Title | Description | Source |
16.11.2023 | Octave Bioscience Receives $10M Grant from The Michael J. Fo... | Octave Bioscience, a Menlo Park, CA-based precision care company for managing multiple sclerosis and... | finsmes.co... |
28.07.2023 | California-based healthcare startup Octave Bioscience raises... | California’s MENLO PARK — –To provide a new standard of treatment for multiple sclerosis (MS) and ot... | vcbay.news... |
26.07.2023 | Octave Bioscience Closes $30M Extension to Series B Funding | Octave Biosciences, a Menlo Park, CA-based commercial stage precision-medicine company, closed a $30... | finsmes.co... |
26.07.2023 | Octave Bioscience Raises $30M Series B Extension | MENLO PARK, CA, Octave Bioscience, a company focused on delivering a new standard of care for mult... | vcnewsdail... |
26.07.2023 | Octave Bioscience scores $30M for neurodegenerative disease ... | Photo: Phil Boorman/Getty Images Octave Bioscience, a company focused on delivering precision medic... | mobihealth... |
27.06.2023 | Nvidia backs Flywheel in $54M round to accelerate medical AI... | Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizi... | venturebea... |
20.12.2020 | Octave Bioscience Secures $32M Series B | MENLO PARK, CA, Octave Bioscience completed a $32 million Series B financing led by Northpond Vent... | vcnewsdail... |
16.07.2018 | Octave Bioscience raises $14 million for MS care management ... | The Series A round follows a previous $2.5 million round of seed funding. The company plans to use t... | medcitynew... |
12.07.2018 | Octave Bioscience Secures $14M in Series A Financing | Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management solution d... | finsmes.co... |
12.07.2018 | Octave Bioscience Grabs $14M for Care Management Platform Fo... | Octave Bioscience lands $14M to bring expertise in chronic neurodegenerative markets and molecular I... | hitconsult... |
Show more